ARIWISE Tablet

Aripiprazole Tablets – PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

ARIWISE Tablet — Aripiprazole IP 5 mg / 10 mg from Trumac Healthcare PCD Pharma Franchise India

Composition Aripiprazole IP 5 mg / 10 mg
Dosage Form Tablet
Pack Type Alu-Alu
Available Strengths ARIWISE-5, ARIWISE-10
MRP See strength-wise pricing below
Therapy Psychiatry – Schizophrenia & bipolar disorder — Atypical antipsychotic (dopamine D2 partial agonist)
Storage Store below 30 °C in a dry place, protected from light. Keep out of reach of children.

📱 WhatsApp Enquiry📞 Call: +919041677932

For chemists, distributors and doctors: ARIWISE (aripiprazole 5 mg / 10 mg tablets) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

See the full neuro & psychiatry range – manufacturer, supplier and PCD franchise: antiepileptics, antidepressants, antipsychotics, pregabalin and gabapentin, dementia and vertigo medicines.

See the full gastro range – manufacturer, supplier and PCD franchise: pantoprazole, rabeprazole, esomeprazole, vonoprazan, domperidone, ondansetron, sucralfate, antacids, laxatives and liver medicines.

Available Strengths

ARIWISE is available in two strengths, both packed 10 x 10 tablets in Alu-Alu strips.

ARIWISE-5

ARIWISE-5 — Aripiprazole IP 5 mg / 10 mg by Trumac Healthcare

Concentration Aripiprazole 5 mg
Delivers Starting / lower dose
Pack 10 x 10 Tablets
MRP ₹ 990

ARIWISE-10

ARIWISE-10 — Aripiprazole IP 5 mg / 10 mg by Trumac Healthcare

Concentration Aripiprazole 10 mg
Delivers Usual starting dose in schizophrenia
Pack 10 x 10 Tablets
MRP ₹ 1380

About ARIWISE Tablet

ARIWISE is Trumac Healthcare’s aripiprazole tablet IP in two strengths – ARIWISE-5 (5 mg, MRP ₹990) and ARIWISE-10 (10 mg, MRP ₹1,380), each 10 x 10 tablets in Alu-Alu packs – made for Trumac at WHO-GMP certified partner units.

Aripiprazole is a widely prescribed atypical antipsychotic. Psychiatrists use it for schizophrenia and for manic episodes of bipolar I disorder, and it is valued because it causes less weight gain, prolactin rise and sedation than many older antipsychotics.

For PCD partners in the neuro-psychiatry segment, ARIWISE adds a high-repeat chronic-therapy product next to Trumac’s risperidone, escitalopram and other CNS brands.

Indications

  • Schizophrenia in adults and adolescents, as prescribed by a psychiatrist
  • Manic or mixed episodes of bipolar I disorder, and prevention of new manic episodes
  • Add-on treatment in depression or other conditions only where the specialist advises

Mechanism of Action

Aripiprazole is a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. It lowers dopamine activity where it is too high and raises it where it is too low, which controls psychotic and manic symptoms with a lower risk of movement side effects and prolactin rise.

Dosage & Administration

Once a day, with or without food, at about the same time. Schizophrenia: usually 10–15 mg a day (maximum 30 mg). Bipolar mania: usually 15 mg a day. The dose is adjusted by the psychiatrist and must be reduced when strong CYP2D6 or CYP3A4 inhibitors (e.g. fluoxetine, paroxetine, ketoconazole) are given. Do not stop suddenly without medical advice.

Side Effects

Restlessness or an inner urge to move (akathisia), insomnia, headache, nausea, dizziness, sleepiness and blurred vision. Compulsive behaviour – pathological gambling, binge eating, compulsive shopping or sexual urges – has been reported; patients and families should report it. Rarely tardive dyskinesia, neuroleptic malignant syndrome (fever, stiffness, confusion – stop and seek care at once), high blood sugar, seizures and low white-cell counts.

Contraindications & Precautions

Do not use in allergy to aripiprazole. Elderly patients with dementia-related psychosis treated with antipsychotics have a higher risk of death and stroke – aripiprazole is not approved for this use. Young people treated for depression should be watched for suicidal thoughts. Use with care in heart disease, low blood pressure, epilepsy, diabetes, history of compulsive behaviour, pregnancy and breastfeeding. Avoid alcohol.

Storage

Store below 30 °C in a dry place, protected from light. Keep out of reach of children.

PCD Pharma Franchise & Third-Party Manufacturing
ARIWISE Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

From Trumac Healthcare, a pharma franchise company in India, available on a monopoly basis – see the neuro-psychiatry products franchise product list (PDF). See our full PCD franchise tablets range. Comparing companies? See the compare neuro PCD companies. No franchise fee; minimum first order ₹25,000 – cost and documents.

Frequently Asked Questions

Who supplies aripiprazole tablets for PCD franchise?

ARIWISE is made for Trumac Healthcare at WHO-GMP certified partner units and offered on a PCD pharma franchise with monopoly rights for your district. No franchise fee; first order from ₹25,000.

Can distributors buy ARIWISE on wholesale?

Yes. Licensed distributors, wholesalers and chemists can buy it in bulk – message us on WhatsApp for net rates. Orders are usually dispatched within 48 hours of confirmation.

Is aripiprazole available for third party manufacturing?

Trumac has no plant of its own; its products are made at WHO-GMP certified partner units. For your own brand, share the quantity and label details and we will tell you what is possible.

What are the strengths, packs and MRPs of ARIWISE?

ARIWISE-5 (aripiprazole 5 mg) MRP ₹990 and ARIWISE-10 (aripiprazole 10 mg) MRP ₹1,380, each 10 x 10 tablets in Alu-Alu packs, as per the current product list.

Does aripiprazole cause weight gain?

Less than most other atypical antipsychotics, but weight, blood sugar and lipids should still be checked during long-term treatment.

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.